Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Summary

The purpose of this study is to evaluate the safety and efficacy of alogliptin tablets when given as monotherapy or add on therapy in participants who are on standard care for management of Type 2 Diabetes Mellitus (T2DM).

Timeline

Start

2017-07-30

Primary completion

2018-01-15

Completion

2018-01-15

Outcome

Outcome not reported

Stopped (Business): “Business decision, no safety or efficacy concerns”

Drugs

Indications